Identifying Emerging Research Collaborations and Networks
نویسندگان
چکیده
منابع مشابه
Identifying Emerging Motif in Growing Networks
As function units, network motifs have been detected to reveal evolutionary mechanisms of complex systems, such as biological networks, food webs, engineering networks and social networks. However, emergence of motifs in growing networks may be problematic due to large fluctuation of subgraph frequency in the initial stage. This paper contributes to present a method which can identify the emerg...
متن کاملIdentifying and controlling emerging foodborne pathogens: research needs.
Systems for managing the risks associated with foodborne pathogens are based on detailed knowledge of the microorganisms and the foods with which they are associated--known hazards. An emerging pathogen, however, is an unknown hazard; therefore, to control it, key data must be acquired to convert the pathogen from an unknown to a known hazard. The types of information required are similar despi...
متن کاملAdvancing translational research collaborations.
In February 2010, the U.S. National Institutes of Health (NIH) sponsored a national Clinical and Translational Science Awards forum titled "Promoting Efficient and Effective Collaborations among Academia, Government and Industry." This forum brought together a broad set of stakeholders who were charged with developing a path for promoting such partnerships. Here, we describe key issues discusse...
متن کاملCreative Research & Development Collaborations
Around the world there are many examples of how universities and industry work together to create new knowledge and new economic value. Motivating creative, smart people to work together can be one of the hardest aspects of such endeavours, especially where various arrangements and agreements need to take the commercial interests of industry into account as well as the highly aspirational inter...
متن کاملEmerging Trends in Biotech/Pharmaceutical Collaborations
This decline can be attributed primarily to a more cautious regulatory climate caused by recent highprofile safety issues. 3 As a result of the heightened bar to obtain FDA approval, the life sciences sector has been plagued by a dearth of new product flow. All players in the industry—even large pharmaceutical companies—have been affected. Notably, only Novartis and GlaxoSmithKline (GSK) releas...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Evaluation & the Health Professions
سال: 2013
ISSN: 0163-2787,1552-3918
DOI: 10.1177/0163278713501693